These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20354203)

  • 21. Cell surface protein glycosylation in cancer.
    Christiansen MN; Chik J; Lee L; Anugraham M; Abrahams JL; Packer NH
    Proteomics; 2014 Mar; 14(4-5):525-46. PubMed ID: 24339177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-linked oligosaccharide processing and tumor cell biology.
    Dennis JW
    Semin Cancer Biol; 1991 Dec; 2(6):411-20. PubMed ID: 1810469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational research on u-PAR.
    Allgayer H
    Eur J Cancer; 2010 May; 46(7):1241-51. PubMed ID: 20362429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
    Ugorski M; Laskowska A
    Acta Biochim Pol; 2002; 49(2):303-11. PubMed ID: 12362971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor cell N-glycans in metastasis.
    Laidler P; Lityńska A
    Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma.
    Cummings J; Ranson M; Butt F; Moore D; Dive C
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):921-4. PubMed ID: 17333190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Glycosphingolipids as tumor markers].
    Lenícková L; Smíd F
    Cas Lek Cesk; 1997 Nov; 136(21):655-61. PubMed ID: 9490212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy.
    Bubendorf L; Sauter G; Moch H; Schmid HP; Gasser TC; Jordan P; Mihatsch MJ
    J Pathol; 1996 Apr; 178(4):437-41. PubMed ID: 8691323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantum dots and their applications in cancer research].
    Chen LD; Li Y; Yuan HY; Pang DW
    Ai Zheng; 2006 May; 25(5):651-6. PubMed ID: 16687092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modification of glycoconjugates during the carcinogenesis: the case of mammary carcinomas].
    Guillot J; Guerry M; Konska G; Caldefie-Chezet F; De Latour M; Penault-Llorca F
    Bull Cancer; 2004 Feb; 91(2):141-58. PubMed ID: 15047454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering new clinical markers in the field of glycomics.
    Telford JE; Doherty MA; Tharmalingam T; Rudd PM
    Biochem Soc Trans; 2011 Jan; 39(1):327-30. PubMed ID: 21265797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Helix pomatia lectin binding glycoproteins in women with breast cancer in relationship to their blood group phenotypes.
    Welinder C; Jansson B; Ferno M; Olson H; Baldetorp B
    J Proteome Res; 2009 Feb; 8(2):782-7. PubMed ID: 18998722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Ferreira JA; Magalhães A; Gomes J; Peixoto A; Gaiteiro C; Fernandes E; Santos LL; Reis CA
    Cancer Lett; 2017 Feb; 387():32-45. PubMed ID: 26828132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate changes in colon carcinoma.
    Itzkowitz S
    APMIS Suppl; 1992; 27():173-80. PubMed ID: 1381596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycosylation in cancer: mechanisms and clinical implications.
    Pinho SS; Reis CA
    Nat Rev Cancer; 2015 Sep; 15(9):540-55. PubMed ID: 26289314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylation and cancer: moving glycomics to the forefront.
    Drake RR
    Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylation markers in cancer.
    Silsirivanit A
    Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant cell glycoproteins and glycolipids.
    Alhadeff JA
    Crit Rev Oncol Hematol; 1989; 9(1):37-107. PubMed ID: 2649262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.